Charles River Laboratories | CRL - Cost Of Sales



Charles River Laboratories reported $713.98M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Agilent USD 850M 48M Jul/2025
Align Technology USD 304.33M 5.18M Jun/2025
Bio-Rad Laboratories USD 306.3M 31.5M Jun/2025
Bruker USD 439.5M 29.3M Jun/2025
Cardinal Health USD 58.05B 5.29B Jun/2025
Charles River Laboratories USD 713.98M 47.54M Jun/2025
Cigna USD 61.44B 2.54B Jun/2025
CVS Health USD 85.32B 5.13B Jun/2025
Danaher USD 2.41B 183M Jun/2025
Dentsply International USD 446M 33M Jun/2025
Elevance Health 36.71B 1.39B Jun/2025
Galapagos EUR 4.71M 9.02M Jun/2025
Hologic USD 447.2M 2.6M Jun/2025
Humana 26.54B 1.15B Mar/2025
Illumina USD 364M 6M Jun/2025
Incyte USD 78.77M 10.96M Jun/2025
IQVIA Holdings USD 2.97B 439M Jun/2025
Laboratory Of America USD 2.55B 152.3M Jun/2025
Lonza CHF 2.47B 532M Dec/2024
McKesson USD 94.55B 7.1B Jun/2025
Merck EUR 2.23B 93M Jun/2025
Mettler Toledo International USD 403.34M 45.48M Jun/2025
Novartis USD 3.32B 95M Jun/2025
Pfizer USD 4.99B 2.4B Jun/2025
Quest Diagnostics USD 1.86B 68M Jun/2025
Revvity USD 327.73M 38.51M Jun/2025
Thermo Fisher Scientific USD 6.81B 751M Jun/2025
United Therapeutics USD 175.2M 102.3M Jun/2025
UnitedHealth 85.8B 6.3B Mar/2025
Waters USD 333.31M 56.57M Jun/2025
West Pharmaceutical Services USD 492.6M 26.5M Jun/2025